Float Short %

8.06

Margin Of Safety %

Put/Call OI Ratio

0.81

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

1.03

Price

16.86

Target Price

18.67

Analyst Recom

2.69

Performance Q

-36.05

Relative Volume

1.42

Beta

0.62

Ticker: STAA

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-01-23	STAA	23.97	0.66	0.66	5000
2025-01-24	STAA	24.4	0.67	2.12	5049
2025-01-27	STAA	24.61	0.85	0.03	5899
2025-01-28	STAA	24.98	0.75	7.90	6336
2025-01-29	STAA	24.18	0.76	0.77	6377
2025-01-30	STAA	23.95	0.77	4.23	6431
2025-01-31	STAA	24.21	0.78	0.59	6521
2025-02-03	STAA	23.4	0.78	0.27	6613
2025-02-04	STAA	23.21	0.78	8.92	6714
2025-02-05	STAA	23.6	0.78	3.00	6792
2025-02-06	STAA	22.82	0.78	0.26	6802
2025-02-07	STAA	21.92	0.72	0.67	7134
2025-02-10	STAA	22.62	0.71	1.56	7157
2025-02-11	STAA	20.99	0.72	0.47	7167
2025-02-12	STAA	16.49	0.72	3.77	7176
2025-02-13	STAA	15.96	0.95	10.47	9078
2025-02-14	STAA	15.34	0.87	0.95	8791
2025-02-18	STAA	16.63	0.88	0.99	9037
2025-02-19	STAA	17.78	0.86	0.24	9540
2025-02-20	STAA	16.87	0.81	1.01	10053
2025-02-21	STAA	16.86	0.81	1.11	10157
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-01-23	STAA	23.95	-103.7	-	0.70
2025-01-24	STAA	24.40	-103.7	-	0.70
2025-01-27	STAA	24.61	-103.7	-	0.70
2025-01-28	STAA	24.97	-103.7	-	0.70
2025-01-29	STAA	24.22	-103.7	-	0.70
2025-01-30	STAA	23.97	-103.7	-	0.70
2025-01-31	STAA	24.26	-103.7	-	0.70
2025-02-03	STAA	23.38	-103.7	-	0.70
2025-02-04	STAA	23.22	-103.7	-	0.70
2025-02-05	STAA	23.63	-103.7	-	0.70
2025-02-06	STAA	22.84	-103.7	-	0.70
2025-02-07	STAA	21.94	-103.7	-	0.70
2025-02-10	STAA	22.61	-103.7	-	0.70
2025-02-11	STAA	21.89	-103.7	-	0.70
2025-02-12	STAA	16.49	-103.7	-	0.70
2025-02-13	STAA	15.96	-103.7	-	0.70
2025-02-14	STAA	15.35	-103.7	-	-0.89
2025-02-18	STAA	16.63	-647.1	-	-0.89
2025-02-19	STAA	17.77	-647.1	-	-0.89
2025-02-20	STAA	16.82	-647.1	-	-0.89
2025-02-21	STAA	16.86	-647.1	-	-0.89
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-01-23	STAA	55.57	2.22	7.22
2025-01-24	STAA	55.57	2.22	7.22
2025-01-27	STAA	55.57	2.24	7.22
2025-01-28	STAA	55.57	2.24	7.45
2025-01-29	STAA	55.57	2.24	7.45
2025-01-30	STAA	55.57	2.24	7.45
2025-01-31	STAA	55.57	2.24	7.45
2025-02-03	STAA	55.57	2.66	7.45
2025-02-04	STAA	55.57	2.66	7.45
2025-02-05	STAA	55.57	2.66	7.45
2025-02-06	STAA	55.57	2.66	7.45
2025-02-07	STAA	55.57	2.66	7.45
2025-02-10	STAA	55.57	7.99	7.46
2025-02-11	STAA	47.38	7.99	7.46
2025-02-12	STAA	47.38	7.99	8.06
2025-02-13	STAA	47.38	7.99	8.06
2025-02-14	STAA	52.96	7.99	8.06
2025-02-18	STAA	163.06	9.45	8.06
2025-02-19	STAA	163.08	9.45	8.06
2025-02-20	STAA	162.66	9.45	8.06
2025-02-21	STAA	162.67	9.45	8.06
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.59

Avg. EPS Est. Next Quarter

-0.6

Insider Transactions

162.67

Institutional Transactions

9.45

Beta

0.62

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

21.67

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

89.7

Max Drawdown 5-Year %

-90.6

Target Price

18.67

P/E

Forward P/E

128.87

PEG

P/S

2.65

P/B

1.94

P/Free Cash Flow

EPS

-0.41

Average EPS Est. Cur. Y

-0.89

EPS Next Y. (Est.)

0.14

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6.44

Relative Volume

1.42

Return on Equity vs Sector %

-14.1

Return on Equity vs Industry %

-4.3

EPS 1 7Days Diff

-1.7

EPS 1 30Days Diff

-1.68

EBIT Estimation

STAAR Surgical Company

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees:

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

stock quote shares STAA – STAAR Surgical Company Stock Price stock today

news today STAA – STAAR Surgical Company stock forecast ,stock prediction 2023 2024 2025

marketwatch STAA – STAAR Surgical Company yahoo finance google finance

stock history STAA – STAAR Surgical Company invest stock market

stock prices STAA premarket after hours

ticker STAA fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: STAA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y